3 Recent Developments in Genomics to Watch

artificial-2970158_960_720.jpg

 

The branch of molecular biology known as genomics is, at its core, the study of life. DNA contains all the information necessary to build a living organism, including the human body. The organization and proliferation of genetic data over the last two decades hasn’t just changed the scope of healthcare, it’s altered our understanding of the nature of life itself.

Within the fascinating field of genomics, which recent developments hold the most potential for disruption? Here are three exciting innovations going on right now.

  1. The Implementation of AI

    When precision medicine was first conceived in the 1990s, the concept of Artificial Intelligence was more science fiction than reality. Today, AI is increasingly being deployed to find the specific intersect between the right drug and the right patient population. Over the last few years, AI has brought a new level of precision to the gene editing process.

    Algorithmic AI programs can predict genomic sequences in cells, suggest where best to edit a strand of DNA, and better analyze the outcomes of specific therapies. There are now a number of large pharmaceutical companies working directly with artificial intelligence firms to better identify potential targets for new bespoke drugs, and certainly more to come.

  1. Genetic Data as the New Cryptocurrency

    Cryptocurrency, a digital currency generated by blockchain technology and secured through encryption, is having a moment. It’s no wonder, then, that biotechnology firms are taking advantage. Several forward-thinking firms are working on using the power of blockchain to generate a plethora of new genetic data with the intention of spurring development within the advanced pharmaceuticals market.

    The idea is to provide individuals with a low-cost option for mapping their own genome, which could potentially offer useful insight for making personal medical decisions. The data would then be encrypted through blockchain technology, meaning it could later be (anonymously) sold to researchers or pharmaceutical companies. The hybrid could be a huge boon for applications in which mass quantities of genetic data are required for advancement.

  1. Improved Sampling Preparation within Proteomics

    The process of solubilizing and stabilizing protein extracts to recover peptides is the foundation of the modern science of proteomics. Optimization of this process depends heavily on factors such as extraction time, sample consistency, and the implementation of automation technology.

    IMCStips, a novel solution by the team at IMCS, are advancing the science of proteomics by drastically improving the sampling process. Using a patented technology known as dispersive pipette extraction, IMCStips achieves rapid isolation among proteins by rapidly binding the sample to loose resins. Ideal for automated sample preparation methods, IMCStips reduce the sample preparation time for protein extraction from hours to minutes, expediting the entire research process.

 

The science of genomics is moving at a breakneck pace. New equipment, new discoveries, and new technologies are opening research avenues scientists deemed impossible a mere decade ago; IMCS is excited to be part of the progress.

For more information on our innovative IMCStips or other products and solutions, reach out to our team today.
888.560.2073